Pelvis-bladder shunt kit

The safety of renal pelvic bladder shunt is achieved by designing a nephrostomy tube with two extended legs and a luer lock compatible tip and applying a hydrophilic layer to the surface of the nephrostomy tube. Stability reduces the risk of complications and improves the quality of life of patients.

CN118946378APending Publication Date: 2024-11-12斯蒂芬·伊万诺维奇·诺维科夫
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030314.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-12-27
Filing Date
2023-12-08
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing renal pelvic cystic shunt devices are prone to postoperative risk of infection and complications caused by uncontrolled bending of the distal end of the nephrostomy duct, such as salt scaling and impaired urine drainage, leading to systemic obstruction and pyel inflammation.

Method used

A renal pelvic cystic shunt kit is designed, including a nephrostomy tube with two extension legs and a luer lock compatible tip, by installing a seal and a silicone membrane at the proximal end of the nephrostomy tube, and fixing the wire to control distal bending, And apply a hydrophilic layer on the surface of the nephrostomy tube to reduce the risk of salt scaling, use colored connectors to reduce the risk of misassembly assembly, and connect to the drug administration/sampling port through a silicone tube.

Benefits of technology

It significantly reduces the risk of postoperative complications, ensures the safety and stability of renal pelvic bladder shunt, reduces the risk of inflammation, and simplifies the positioning and fixation of nephrostomy tubes in the renal pelvis, improving the quality of life of patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118946378A_ABST
    Figure CN118946378A_ABST
Patent Text Reader

Abstract

The invention relates to a medical device for treating patients suffering from ureteral obstruction, including small animals. The pelvis-bladder shunt kit includes a connector; a nephrostomy tube to be mounted in the pelvis; a bladder fistulization tube to be installed in the bladder; a drug administration, sampling, or irrigation port; the silicone tube is connected with the connector and the port; and the connecting coupling piece is used for fixing the near ends of the nephrostomy tube, the bladder stomy tube and the silicone tube on the extension legs of the connector. The connector may hydraulically connect the port, the nephrostomy tube, and the cystostomy tube. A line is placed in the slot of the nephrostomy tube through a cross-hole in its folded distal end. The proximal end of the nephrostomy tube has two extension legs, and the end of the wire passes through a membrane on a cap mounted on one of the legs and is secured with a seal. The proximal end of the nephrostomy tube may be trimmed. The technical result is that safe pelvis-bladder shunt is ensured by minimizing the likelihood of complications by reducing the risk of inflammation, easily adjusting the position of the nephrostomy tube within the pelvis, and improving the fixation of the nephrostomy tube and the cystostomy tube within the patient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to medical devices for treating patients (including small animals) suffering from ureteral obstruction. More particularly, the present invention relates to procedures for implanting a pelvic shunt device into the abdominal cavity of a patient. Background Art

[0002] Known intraperitoneal urine diversion (shunt) devices are currently the best solution to the problems that arise when using external nephrostomy tubes, such as infection, irregular patient care, urine leakage or displacement.

[0003] A renal pelvic shunt device is known in the prior art (patent number US 8808261 B2, IPC A61B17 / 11, A61B5 / 20, A61B6 / 508, published on August 19, 2014), which includes a nephrostomy tube and a cystostomy tube, the proximal ends of which are hydraulically connected by a connector, the connector having an internal fluid reservoir and a drug application / sampling point closed by a self-sealing silicone diaphragm. The connector is designed to position the injection site subcutaneously close to the patient's skin after the ureteral shunt device is implanted in the patient's body, and enter the insertion site through the skin, thereby achieving diagnostic and therapeutic surgery.

[0004] A disadvantage of the known devices is that there may be post-operative complications due to the risk of infection of the drug administration / sampling ports.

[0005] The closest device in technology is a ureteral shunt device (patent application number US2021402136 A1, IPCA61M25 / 00; A61M39 / 02, published on December 12, 2021), which includes a nephrostomy tube and a cystostomy tube, the proximal ends of which are hydraulically connected by a connector. The device also includes a drug administration / sampling port closed with a self-sealing silicone diaphragm and hydraulically connected to the connector via a silicone tube. The silicone tube defines a non-dynamic volume between the adapter and the sampling / flushing port through which urine does not pass. Therefore, the non-dynamic volume acts as a reservoir to prevent infection.

[0006] A disadvantage of the known device is that there may be postoperative complications due to uncontrolled bending of the distal end of the nephrostomy tube. Furthermore, the known device is designed so that after the nephrostomy tube is installed, the wires tightening the folded distal end cannot be removed, which leads to the risk of salt encrustation of the nephrostomy tube, causing systemic obstruction and impaired urine drainage from the kidneys, and ultimately leading to inflammation of the renal pelvis. Summary of the invention

[0007] The present invention aims to solve the problem of eliminating postoperative complications, thereby significantly improving the quality of life of patients.

[0008] The technical effect is to ensure safe pelvic shunting by minimizing the possibility of complications, by reducing the risk of inflammation, easily adjusting the position of the nephrostomy tube in the renal pelvis, and improving the fixation of the nephrostomy and cystostomy tubes in the patient.

[0009] The technical effect is achieved by the following method: the renal pelvis bladder shunt kit includes a connector; a nephrostomy tube to be installed in the renal pelvis; a bladder stomy tube to be installed in the bladder; a drug administration, sampling or flushing port; a silicone tube connecting the connector and the port; and a connecting coupling. A wire is placed in the groove of the nephrostomy tube and passed through a cross hole at its folded distal end. According to the present invention, the proximal end of the nephrostomy tube has two extended legs, and the end of the wire passes through a membrane on a cover installed on one of the legs and is fixed with a seal.

[0010] Furthermore, according to the present invention, the membrane and the seal on the cap are made of silicone and the extension legs are provided with tips that are compatible with a Luer lock.

[0011] Furthermore, according to the present invention, the outer surface of the nephrostomy catheter is covered with a hydrophilic layer.

[0012] Furthermore, according to the present invention, a cuff is installed at the distal end of the pyelostomy tube and the cystostomy tube and is fixed to the catheter by a silicone ring.

[0013] In addition, according to the present invention, the connector can have three extension legs for connecting the proximal ends of the silicone tube, the pyelostomy tube and the cystostomy tube. The connector can also have a second nephrostomy tube to be installed in the renal pelvis of the patient's second kidney, and the connector has four extension legs for connecting the proximal ends of the silicone tube, the pyelostomy tube and the cystostomy tube.

[0014] Furthermore, according to the present invention, the connector extension legs have colored fittings thereon.

[0015] Furthermore, according to the present invention, the kit also includes a device for installing a pyelostomy tube and a cystostomy tube into a patient, including a guide wire with a distal introducer, a core rod with a needle, and a plastic cannula or a Seldinger needle with a stylet.

[0016] The present invention is based on solving the problem of ureteral obstruction caused by the migration of kidney stones from the renal collecting system into the ureteral lumen accompanied by inflammation, and the problem of acute renal failure caused by impaired urine outflow from the kidney.

[0017] Reduce complications by safely inserting the nephrostomy tube into the renal pelvis. The folded distal end of the nephrostomy tube secures its position in the renal pelvis. By using a wire to change the curvature of the distal end, the optimal position within the renal pelvis is determined, eliminating the risk of obstruction due to kinking and mobility of the nephrostomy tube, also reducing the risk of complications.

[0018] Unlike known similar devices, the proximal end of the nephrostomy tube included in the kit has two extension legs with Luer lock compatible tips. The presence of two Luer lock tips at the proximal end allows simultaneous pelvic staining during installation of the nephrostomy tube to control the correct positioning of the distal end of the nephrostomy tube by one Luer lock. The second Luer lock is used to remove the polypropylene fixation wire, which, when tightened, achieves optimal bending of the distal end of the nephrostomy tube and thereby correctly positions the nephrostomy tube in the renal pelvis.

[0019] The presence of two extended legs at the proximal end of the nephrostomy tube allows safe removal of the polypropylene thread after positioning the distal end, which significantly reduces the risk of encrustation.

[0020] The presence of two Luer lock tips at the proximal end of the nephrostomy tube can significantly simplify its positioning in the renal pelvis by securing the mandrel to the nephrostomy tube, which also facilitates safe shunt surgery.

[0021] Furthermore, salt scaling of the nephrostomy tube was reduced by additionally coating its outer surface with a hydrophilic layer.

[0022] The kit uses smaller plastic ports for medication administration / sampling, which reduces surgical trauma (smaller incision during installation) and reduces pain (fewer fixation points). The risk of incorrect assembly of the device during ureteral diversion surgery is also reduced by using colored connector accessories in the kit.

[0023] The proposed pelvic shunt kit may include alternative devices for inserting the catheter into the patient, which in some cases provides intraoperative advantages, reduces operating time and simplifies the procedure. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] The invention is described by means of graphic material of specific embodiments thereof, in which:

[0025] Figure 1 It is a renal pelvic shunt kit;

[0026] Figure 2 is a diagram of a shunt device with a nephrostomy tube;

[0027] Figure 3 Diagram of a shunt device with two nephrostomy tubes. DETAILED DESCRIPTION

[0028] Pelvic shunt kit includes connector 1 ( Figure 1 );a nephrostomy tube 2 to be installed in the patient's renal pelvis;a cystostomy tube 3 to be installed in the bladder;a drug administration, sampling or flushing port 4;a silicone tube 5 designed to connect the connector 1 and the port 4, and a connecting coupler 6, which is made of silicone, for example, and is designed to fix the proximal ends of the nephrostomy tube 2, the cystostomy tube 3 and the silicone tube 5 on the extension leg of the connector 1.

[0029] The connector 1 can hydraulically connect the port 4, the nephrostomy tube 2 and the cystostomy tube 3. The kit components connected in this way constitute a renal pelvic shunt device ( Figure 2 or 3). For example, to facilitate drug administration, the distal end of the port 4 and the silicone tube 5 are located subcutaneously, so that the inlet 7 of the port 4 closed by the silicone diaphragm is close to the patient's skin.

[0030] In order to position the proximal ends of the nephrostomy tube 2, cystostomy tube 3 and silicone tube 5, the connector 1 has extension legs, the number of which varies according to the need to shunt one or two kidneys.

[0031] Thus, the connector 1 may have three extension legs for connecting the silicone tube 5 designed to be connected to the port 4, the proximal end of the nephrostomy tube 2 and the cystostomy tube 3 ( Figure 2 However, if pelvic shunt is required for both kidneys, a connector 1 with four extension legs is used to connect the silicone tube 5, the two nephrostomy tubes 2 for both kidneys of the patient, and the proximal ends of the cystostomy tube 3 ( Figure 3 ).

[0032] In order to facilitate and safely perform the operation of installing the nephrostomy tube 2, the cystostomy tube 3 and the port 4, the extension legs of the connector 1 are equipped with colored accessories: the gold accessory 8.1 is installed on the extension leg for connecting to the cystostomy tube 3, the silver accessory 8.2 is installed on the extension leg connected to the port 4 through the silicone tube 5, and the blue accessory 8.3 is installed on the extension leg for connecting one or two nephrostomy tubes 2 ( Figure 2 and 3 ).

[0033] The nephrostomy tube 2 is made of an elastic material, such as polyurethane, and the outer surface of the nephrostomy tube is coated with a hydrophilic layer to protect it from organic formations (salt scale, biofilm, etc.), thereby significantly reducing the risk of infection. The cystostomy tube 3 is made of silicone.

[0034] The distal end of the nephrostomy tube 2 is foldable, allowing the position of the nephrostomy tube 2 in the renal pelvis to be fixed. The distal end of the nephrostomy tube 2 has a cross hole 9 for the outflow of fluid from the renal pelvis.

[0035] To secure it to the patient's organ during the healing period and to prevent urine leakage, each catheter 2 or 3 has a cuff 10 at its distal end, secured to the catheter by a silicone ring. The cuff 10 can be made of PTFE or fluoroplastic-4. The proximal end of the nephrostomy tube has two extension legs with Luer lock tips for connection, for example, to a device for mounting the nephrostomy tube 2.

[0036] The diameter of the catheters 2 and 3 is selected to ensure optimal drainage. The length of the catheters 2 and 3 can be shortened according to the anatomical dimensions of the specific patient.

[0037] In order to conveniently and safely insert the nephrostomy tube 2 into the renal pelvis, a wire 11 is placed in the groove of the nephrostomy tube 2 and passed through the cross hole 9 at the distal end of the tube 2. The end of the wire 11 passes through the silicone membrane on the cover 12, which is mounted on an extended leg of the nephrostomy tube 2 and is designed to seal and partially fix the wire 11. The end of the wire 11 passing through the membrane of the cover 12 is fixed by the silicone seal 13 as follows: the ends of the wire 11 pass through the silicone seal 13 and are knotted with each other. Therefore, the silicone seal 13 is designed to fix the tension of the wire 11 to force the distal end of the nephrostomy tube 2 to bend. The wire 11 is made of a non-absorbable material, such as polypropylene.

[0038] In addition to the elements that make up the pelvic shunt device, the kit also includes a device for installing the nephrostomy tube 2, cystostomy tube 3 and port 4 into the patient's body, which may include a guide wire 17 with a distal introducer enclosed in a protective plastic tube 14; a mandrel 15 with a needle 16; a Seldinger needle 18 and a plastic cannula 19 with a stylet 20. Figure 1 )

[0039] The devices included in the kit help the physician select the technique for inserting the renal shunt device based on the patient's anatomy.

[0040] The pelvic shunt surgery was performed as follows.

[0041] Under fluoroscopic or ultrasound control, the renal pelvis is punctured using a Seldinger needle 18 or a plastic cannula 19 with a stylet 20 until urine appears at the needle tip. A bacterial culture sample is taken from the kidney. Then, the guide wire 17 is inserted into the kidney through the Seldinger needle 18 or the plastic cannula 19, wherein the stylet 20 is previously removed and positioned annularly (in a circular shape) in the renal pelvis under fluoroscopic or ultrasound data guidance. Thereafter, the Seldinger needle 18 or the plastic cannula 19 is removed from the kidney without moving the guide wire 17 itself.

[0042] Then, the core rod 15 without the needle 16 is inserted into the nephrostomy tube 2 and fixed by clockwise rotating the nephrostomy tube 2 and the Luer lock tip at the end of the hollow core rod 15. Then, the nephrostomy tube 2 with the core rod 15 fixed is inserted into the renal pelvis along the guide wire 17 under fluoroscopy or ultrasound.

[0043] When the distal end of the nephrostomy tube 2 enters the renal pelvis, the mandrel 15 is disconnected from the Luer lock of the nephrostomy tube 2, and the nephrostomy tube 2 is pushed into the renal pelvis along the guide wire 17 without moving the mandrel 15 until it reaches the cuff 10. Then, the mandrel 15 and the guide wire 17 are completely removed from the nephrostomy tube 2 under fluoroscopy or ultrasound.

[0044] Another method of inserting the nephrostomy tube 2 into the renal pelvis involves using the needle 16 of the mandrel 15 instead of the Seldinger needle 18 or the plastic cannula 19 with the stylet 20 .

[0045] The core rod 15 with the needle 16 is inserted into the nephrostomy tube 2, and the core rod 15 is fixed to the nephrostomy tube 2 by clockwise rotating the Luer lock tip at the end of the nephrostomy tube 2. The nephrostomy tube 2 and the core rod 15 with the needle 16 assembled in this way under fluoroscopy or ultrasound are inserted into the patient's body until the distal end of the nephrostomy tube 2 enters the renal pelvis.

[0046] Then, by turning the Luer lock tip counterclockwise, the fixed mandrel 15 with the needle 16 is disconnected from the nephrostomy tube 2. The nephrostomy tube 2 is inserted into the renal pelvis without moving the mandrel 15 until the cuff 10 is reached. Then, the mandrel 15 with the needle 16 is completely removed under fluoroscopy or ultrasound.

[0047] Therefore, the device included in the kit helps the doctor to select the technique for inserting the nephrostomy tube 2 into the renal pelvis, increasing the convenience and safety of the pelvic bladder shunt surgery.

[0048] If necessary, the distal end of the nephrostomy tube 2 located in the renal pelvis can be further bent by pulling the end of the polypropylene thread 11 passed through the distal hole of the nephrostomy tube 2. The end of the polypropylene thread 11 is pulled at the outlet of the cap with silicone membrane 12 and then fixed with a silicone seal 13. The correct positioning of the distal end of the nephrostomy tube 2 is controlled by injecting contrast medium into the freely extending leg with a Luer lock tip.

[0049] Using the cuff 10, the nephrostomy tube 2 is fixed by applying cyanoacrylate medical glue to the surface of the cuff 10 that contacts the kidney and then pressing until the glue polymerizes. After the nephrostomy tube 2 is fixed, the system is checked for leaks by injecting 1 to 10 mL of nonionic contrast medium into the freely extending leg of the nephrostomy tube 2 with a Luer lock tip.

[0050] In order to reduce the risk of urate scaling and biofilm formation and thus the possibility of post-intervention inflammatory processes, the polypropylene thread 11 is removed from the nephrostomy tube 2. While keeping the nephrostomy tube 2 connected to the kidney without leaks, one end of the thread 11 is cut and the thread 11 is removed from the extended leg of the nephrostomy tube 2 closed by the cap 12 with a silicone membrane by pulling the uncut part and the seal 13 located thereon.

[0051] The next step is to install the cystostomy tube3. To do this, the bladder is isolated from the abdominal organs with wet gauze and the correct anatomical position is maintained, avoiding distorting the urethra. In the avascular area of ​​the top of the bladder, an untightened purse-string suture is applied using a monofilament non-absorbable suture, such as 4\0 polypropylene. In the center of the purse-string suture, the serosa and muscular layer of the bladder are coagulated using a monopolar coagulator with a diameter of 1.5 to 2.5 mm, avoiding penetration of the mucosal layer.

[0052] The center of the purse string suture is punctured using a Seldinger needle 18 or a plastic cannula 19 with a stylet 20, and then a guide wire 17 is inserted through the Seldinger needle 18 or the plastic cannula 19, with the stylet 20 removed. The hollow mandrel 15 without the needle 16 is inserted into the cystostomy tube 3. The cystostomy tube 3 with the hollow mandrel 15 inserted is inserted into the bladder along the guide wire 17. The purse string suture is then tightened, and then the mandrel 15 and the guide wire 17 are completely removed.

[0053] Another method of inserting the silicone cystostomy catheter 3 into the bladder cavity involves using the needle 16 of the mandrel 15 instead of the Seldinger needle 18 or the plastic cannula 19 with the stylet 20 .

[0054] The hollow mandrel 15 is inserted into the cystostomy tube 3, and then the needle 16 is inserted into the mandrel 15 and fixed to the Luer lock tip of the mandrel 15 by rotating it clockwise. The cystostomy tube 3 and the mandrel 15 with the needle 16 are assembled in this way, and the center of the purse string suture is punctured until the distal end of the cystostomy tube 3 enters the bladder cavity. Then, by rotating the Luer lock tip counterclockwise, the needle 16 of the mandrel 15 is disconnected and removed from the hollow mandrel 15. The purse string suture is then tightened, and the mandrel 15 is also completely removed thereafter.

[0055] Therefore, the device included in the kit allows the doctor to select the technique for inserting the cystostomy tube 3 into the bladder, increasing the convenience and safety of pelvic bladder shunt.

[0056] After the cystostomy tube 3 is inserted, its cuff 10 is fixed to the bladder wall using 3 or 4 simple ligature sutures made of non-absorbable material, such as 4\0 polypropylene. The interface between the cuff 10 and the bladder wall is sealed by applying cyanoacrylate medical glue to the surface of the cuff 10 and pressing the cuff 10 against the bladder wall until the glue polymerizes.

[0057] After installing the nephrostomy tube 2 and the cystostomy tube 3, their proximal ends are trimmed to the required length according to the patient's body shape. The connecting coupling 6 is placed on the proximal ends of the catheters 2 and 3, and the catheters 2 and 3 are connected to the fittings 8.1 and 8.3 ( Figure 2 and 3). The colored fittings facilitate the correct connection of the catheters 2 and 3 to the connector 1: the proximal end of the cystostomy tube 3 is connected to the gold fitting 8.1 and the proximal end of the nephrostomy tube 2 is connected to the blue fitting 8.3.

[0058] Use silicone tubing 5 to connect port 4 to the connector, with the connection coupling 6 placed on it. Connect its proximal end to the silver fitting 8.2 of connector 1 in the same way.

[0059] A channel is then created in the rectus abdominis muscle using a blunt approach with an atraumatic hemostat. Through the created channel, the silicone tube 5 is extended into the subcutaneous space. The distal end of the silicone tube 5, with the coupling 6 pre-installed, is attached to the fitting 21 of the port 4, and then the coupling 6 is lowered all the way down to the fitting of the port 4, thereby securing the connection.

[0060] Then, use a monofilament non-absorbable suture, such as polypropylene 2\0, to fix port 4 laterally to the abdominal wall muscle with three simple knotted sutures, 1 to 3 cm away from the incision line. Afterwards, check the assembled system for leaks by puncturing port 4 using a 19-22G diameter Huber needle (not included in the kit) and injecting 2 to 20 mL of sterile nonionic contrast medium under fluoroscopy. If there is no leak, aspirate the fluid injected into the system and remove the Huber needle from the inlet 7 of port 4.

[0061] The surgical access point is then closed in layers using commonly employed techniques without capturing portions of the kidney's urinary drainage system with sutures.

[0062] Therefore, the proposed kit provides a safe pelvic bladder shunt by allowing the removal of the polypropylene thread from the nephrostomy tube after the nephrostomy tube is placed in the renal pelvis due to the presence of two extension legs and two Luer lock tips at the proximal end of the nephrostomy tube.

Claims

1. A renal pelvis shunt kit comprising a connector; a nephrostomy tube to be deployed in the renal pelvis; a cystostomy tube to be deployed in the bladder; a drug administration, sampling or flushing port ; a silicone tube for attaching the connector to the port; A coupling for fixing the proximal ends of the nephrostomy tube, cystostomy tube and silicone tube on the extension legs of the connector, wherein the connector is designed to hydraulically connect the ports, nephrostomy tube and cystostomy tube to each other, and the longitudinal groove of the nephrostomy tube includes a wire passing through its distal cross hole, and the distal end is folded, characterized in that the proximal end of the nephrostomy tube has two extension legs, and the ends of the wire pass through a membrane on a cover mounted on one of the extension legs and are sealed, wherein the proximal end of the nephrostomy tube is designed to be trimmable.

2. The kit of claim 1, wherein the cover membrane and seal are made of silicone.

3. The kit of claim 1, wherein the extension leg of the nephrostomy tube has a Luer lock tip thereon.

4. The kit of claim 1, wherein the outer surface of the nephrostomy tube has a hydrophilic layer.

5. The kit of claim 1, wherein a cuff is installed at the distal end of the pyelostomy tube and the cystostomy tube and fixed to the catheter by a silicone ring.

6. The kit of claim 1, wherein the connector has three extension legs for connecting the proximal ends of the silicone tube, pyelostomy tube, and cystostomy tube.

7. A kit as described in claim 1, wherein there is a second nephrostomy tube to be installed in the renal pelvis of the patient's second kidney, and the connector has four extension legs for connecting the proximal ends of the silicone tube, nephrostomy tube and cystostomy tube.

8. A kit as claimed in claim 6 or 7, wherein the connector extension legs have coloured fittings thereon.

9. The kit of claim 1, wherein the proximal end of the cystostomy tube is trimmable.

10. A kit as described in claim 1, wherein there is a fixing device for installing the nephrostomy tube and cystostomy tube into the patient's body, including a guide wire composed of a plastic tube with a terminal introducer, a core rod with a needle, and a plastic cannula or a Seldinger needle with a stylet.